PDF(1295 KB)
Expressions of IL-33, IL-8, and NETs in lung tissue of patients with chronic obstructive pulmonary disease and their significances
Yu ZHANG,Xianling LU
PDF(1295 KB)
PDF(1295 KB)
Expressions of IL-33, IL-8, and NETs in lung tissue of patients with chronic obstructive pulmonary disease and their significances
)Objective To discuss the expression levels of interleukin-33 （IL-33）， interleukin-8 （IL-8）， and the major components of neutrophil extracellular traps （NETs）-myeloperoxidase （MPO） and citrullinated histone H3 （CitH3） in lung tissue of the patients with chronic obstructive pulmonary disease （COPD）， and to clarify the effects of IL-33， IL-8， and NETs on the occurrence and development of COPD. Methods Seventy-seven patients underwent lobectomy due to pulmonary nodules or lung tumors were selected as the subjects and divided into non-smoking control group （20 cases）， smoking control group （18 cases）， non-smoking COPD group （19 cases）， and smoking COPD group （20 cases）.The lung tissue samples from the subjects were collected.HE staining was used to observe the pathomorphology of lung tissue of the patients in various groups；immunohistochemisty staining was used to detect the expression levels of IL-33， IL-8， CitH3， and MPO proteins in lung tissue of the patients in various groups； Spearman correlation analysis was used to detect the relationship between expression levels of IL-33， IL-8， CitH3， and MPO proteins in lung tissue of the patients in COPD groups and their correlations with lung function index， mean linear intercept （MLI）， mean alveolar number （MAN）， and Bosken score. Results Compared with non-smoking control group， the airway Bosken score of the patients in smoking control group was significantly increased （P<0.001）； compared with non-smoking control and smoking control groups， the airway Bosken score and MLI of the patients in non-smoking COPD group were significantly increased （P<0.05）， while the MAN was significantly decreased （P<0.05）； compared with non-smoking control group， smoking control group， and non-smoking COPD group， the airway Bosken score of the patients in smoking COPD group was significantly increased （P<0.05）； compared with non-smoking control group and smoking control group， the MLI of the patients in smoking COPD group was significantly increased （P<0.05）， and the MAN was significantly decreased （P<0.05）. The immunohistochemisty staining results showed that compared with non-smoking control group， smoking control group， and non-smoking COPD group，the expression level of IL-33 in lung tissue of the patients in smoking COPD group was significantly increased （P<0.05）； compared with non-smoking control group and smoking control group，the expression levels of IL-8， CitH3， and MPO proteins in lung tissue of the patients in smoking COPD group were significantly increased （P<0.05）. Compared with non-smoking control group and smoking control group， the expression levels of IL-33， IL-8， CitH3， and MPO proteins in lung tissue of the patients in non-smoking COPD group were significantly increased （P<0.05）.The Spearman correlation analysis results showed that there was a negative correlation between the expression level of IL-33 protein and forced expiratory volume in first second/forced vital capacity （FEV1/FVC）， the forced expiratory volume in first second predicted FEV1 （FEV1%pred）， and MAN （r=－0.406， P<0.05； r=－0.493， P<0.01； r=－0.567， P<0.05） in lung tissue of the patients in COPD group， and there was a positive correlation with Bosken score and MLI （r=0.935， P<0.001； r=0.590， P<0.001）；the expression level of IL-8 protein in lung tissue of the patients in COPD group was negatively correlated with the FEV1/FVC， FEV1%pred， and MAN （r=－0.527， P<0.01； r=－0.497， P<0.01； r=－0.463， P<0.01）， and was positively correlated with the Bosken score and MLI （r=0.557， P<0.001； r=0.486， P<0.01）； the expression level of CitH3 protein in lung tissue of the patients in COPD group was negatively correlated with the FEV1/FVC， FEV1%pred， and MAN （r=－0.527， P<0.01； r=－0.640， P<0.001； r=－0.531， P<0.01）， and was positively correlated with the Bosken score and MLI （r=0.565， P<0.001； r=0.585， P<0.001）；the expression level of MPO protein in lung tissue of the patients in COPD group was positively correlated with the FEV1/FVC （r=－0.329， P<0.05）， and was positively correlated with the Bosken score （r=0.410， P<0.05）； the expression level of IL-8 protein was positively correlated with the expression levels of CitH3 and MPO proteins （r=0.390，P<0.05； r=0.349， P<0.05）； the expression level of IL-33 protein was positively correlated with the expression levels of IL-8， CitH3， and MPO proteins （r=0.602，P<0.001； r=0.616，P<0.001； r=0.387， P<0.05）. Conclusion The expression levels of IL-33， IL-8， and NETs in lung tissue of the COPD patients are increased， and they may be involved in the chronic inflammation of COPD and correlated with the severity of the disease.
Chronic obstructive pulmonary disease / Interleukin-33 / Interleukin-8 / Neutrophil extracellular traps / Smoking
R563.9
| 1 | CELLI B， FABBRI L， CRINER G， et al. Definition and nomenclature of chronic obstructive pulmonary disease： time for its revision［J］. Am J Respir Cri Care Med，2022， 206（11）： 1317-1325. |
| 2 | HERRERO-CERVERA A， SOEHNLEIN O， KENNE E.Neutrophils in chronic inflammatory diseases［J］. Cell Mol Immunol， 2022， 19（2）： 177-191. |
| 3 | LI T， ZHANG Z， LI X， et al. Neutrophil extracellular traps： signaling properties and disease relevance［J］. Mediators Inflamm， 2020， 2020： 1-14. |
| 4 | D?RING Y， SOEHNLEIN O， WEBER C. Neutrophil extracellular traps in atherosclerosis and atherothrombosis［J］. Circ Res， 2017， 120（4）： 736-743. |
| 5 | 林笑颖， 周明倩， 李海昌. 中性粒细胞胞外诱捕网在系统性红斑狼疮发病机制中作用的研究进展［J］. 吉林大学学报（医学版）， 2018， 44（4）： 886-890. |
| 6 | GRABCANOVIC-MUSIJA F， OBERMAYER A， STOIBER W， et al. Neutrophil extracellular trap （NET） formation characterises stable and exacerbated COPD and correlates with airflow limitation［J］. Respir Res， 2015， 16（1）： 59. |
| 7 | AN Z， LI J， YU J， et al. Neutrophil extracellular traps induced by IL-8 aggravate atherosclerosis via activation NF-κB signaling in macrophages［J］. Cell Cycle， 2019， 18（21）： 2928-2938. |
| 8 | SHANG J， ZHAO J， WU X， et al. Interleukin-33 promotes inflammatory cytokine production in chronic airway inflammation［J］. Biochem Biol， 2015， 93（4）： 359-366. |
| 9 | 范 傲， 黄 钟， 段宇清， 等.慢性阻塞性肺疾病患者血浆中性粒细胞胞外诱捕网和白细胞介素-8及白细胞介素-33的表达水平及其临床意义［J］. 中国呼吸与危重监护杂志， 2022， 21（2）： 84-89. |
| 10 | SANTOS A， MARTíN P， BLASCO A， et al. NETs detection and quantification in paraffin embedded samples using confocal microscopy［J］. Micron， 2018， 114： 1-7. |
| 11 | SHENG H， ZHANG Y， SHI X， et al. Functional， ultrastructural， and transcriptomic changes in rat diaphragms with different durations of cigarette smoke exposure［J］. Int J Chron Obstruct Pulmon Dis， 2020， 15： 3135-3145. |
| 12 | ZHENG X R， ZHANG L Y， CHEN J， et al. Dendritic cells and Th17/Treg ratio play critical roles in pathogenic process of chronic obstructive pulmonary disease［J］. Biomedicine Pharmacother， 2018， 108： 1141-1151. |
| 13 | HIKICHI M， MIZUMURA K， MARUOKA S， et al. Pathogenesis of chronic obstructive pulmonary disease （COPD） induced by cigarette smoke［J］. J Thorac Dis， 2019， 11（）： S2129-S2140. |
| 14 | PéREZ-RUBIO G， CóRDOBA-LANúS E， CUPERTINO P， et al. Role of genetic susceptibility in nicotine addiction and chronic obstructive pulmonary disease［J］. Rev Invest Clín， 2019， 71（1）：36-54. |
| 15 | DICKER A J， CRICHTON M L， PUMPHREY E G， et al. Neutrophil extracellular traps are associated with disease severity and microbiota diversity in patients with chronic obstructive pulmonary disease［J］. J Allergy Clin Immunol， 2018， 141（1）： 117-127. |
| 16 | PEDERSEN F， MARWITZ S， HOLZ O， et al. Neutrophil extracellular trap formation and extracellular DNA in sputum of stable COPD patients［J］. Respir Med， 2015， 109（10）： 1360-1362. |
| 17 | ZHANG H， QIU S L， TANG Q Y， et al. Erythromycin suppresses neutrophil extracellular traps in smoking-related chronic pulmonary inflammation［J］. Cell Death Dis， 2019， 10（9）： 678. |
| 18 | MATSUSHIMA K， YANG D， OPPENHEIM J J. Interleukin-8： an evolving chemokine［J］. Cytokine， 2022， 153： 155828. |
| 19 | NIE M， YANG L B， BI X W， et al. Neutrophil extracellular traps induced by IL8 promote diffuse large B-cell lymphoma progression via the TLR9 signaling［J］. Clin Cancer Res， 2019， 25（6）： 1867-1879. |
| 20 | HUDOCK K M， COLLINS M S， IMBROGNO M，et al.Neutrophil extracellular traps activate IL-8 and IL-1 expression in human bronchial epithelia［J］. Am J Physiol Lung Cell Mol Physiol， 2020， 319（1）： L137-L147. |
| 21 | WU H X， YANG S F， WU X J， et al. Interleukin-33/ST2 signaling promotes production of interleukin-6 and interleukin-8 in systemic inflammation in cigarette smoke-induced chronic obstructive pulmonary disease mice［J］. Biochem Biophys Res Commun，2014，450（1）： 110-116. |
| 22 | WANG X D， LI X Y， CHEN L Y， et al. Interleukin-33 facilitates cutaneous defense against Staphylococcus aureus by promoting the development of neutrophil extracellular trap［J］. Int Immunopharmacol， 2020， 81： 106256. |
| 23 | TEMBHRE M K， SRIWASTVA M K， HOTE M P， et al. Interleukin-33 induces neutrophil extracellular trap （NET） formation and macrophage necroptosis via enhancing oxidative stress and secretion of proatherogenic factors in advanced atherosclerosis［J］. Antioxidants， 2022， 11（12）： 2343. |
| 24 | GEORGAKIS S， GKIRTZIMANAKI K， PAPADAKI G， et al. NETs decorated with bioactive IL-33 infiltrate inflamed tissues and induce IFN-α production in patients with SLE［J］. JCI Insight， 6（21）： e147671. |
| 25 | KEARLEY J， SILVER J S， SANDEN C， et al. Cigarette smoke silences innate lymphoid cell function and facilitates an exacerbated type Ⅰ interleukin-33-dependent response to infection［J］. Immunity， 2015， 42（3）： 566-579. |
| 26 | XIA J， ZHAO J L， SHANG J， et al. Increased IL-33 expression in chronic obstructive pulmonary disease［J］. Am J Physiol Lung Cell Mol Physiol， 2015， 308（7）： L619-L627. |
/
| 〈 |
|
〉 |
AI Summary
